Reduction in Ki-67 in Benign Breast Tissue of High-Risk Women with the Lignan Secoisolariciresinol Diglycoside
- 1 October 2010
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 3 (10), 1342-1350
- https://doi.org/10.1158/1940-6207.capr-10-0022
Abstract
Preclinical and correlative studies suggest reduced breast cancer with higher lignan intake or blood levels. We conducted a pilot study of modulation of risk biomarkers for breast cancer in premenopausal women after administration of the plant lignan secoisolariciresinol given as the diglycoside (SDG). Eligibility criteria included regular menstrual cycles, no oral contraceptives, a >3-fold increase in 5-year risk, and baseline Ki-67 of ≥2% in areas of hyperplasia in breast tissue sampled by random periareolar fine-needle aspiration (RPFNA) during the follicular phase of the menstrual cycle. SDG (50 mg/d) was given for 12 months, followed by repeat RPFNA. The primary end point was change in Ki-67. Secondary end points included change in cytomorphology, mammographic breast density, serum bioavailable estradiol and testosterone insulin-like growth factor-I and IGF-binding protein-3, and plasma lignan levels. Forty-five of 49 eligible women completed the study with excellent compliance (median = 96%) and few serious side effects (4% grade 3). Median plasma enterolactone increased ∼9-fold, and total lignans increased 16-fold. Thirty-six (80%) of the 45 evaluable subjects showed a decrease in Ki-67, from a median of 4% (range, 2-16.8%) to 2% (range, 0-15.2%; P < 0.001, Wilcoxon signed rank test). A decrease from baseline in the proportion of women with atypical cytology (P = 0.035) was also observed. Based on favorable risk biomarker modulation and lack of adverse events, we are initiating a randomized trial of SDG versus placebo in premenopausal women. Cancer Prev Res; 3(10); 1342–50. ©2010 AACR.Keywords
This publication has 82 references indexed in Scilit:
- Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasiaBreast Cancer Research and Treatment, 2009
- Reproducibility of Random Periareolar Fine Needle Aspiration in a Multi-Institutional Cancer and Leukemia Group B (CALGB) Cross-Sectional StudyCancer Epidemiology, Biomarkers & Prevention, 2009
- Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studiesBritish Journal of Cancer, 2009
- Flaxseed lignan attenuates high-fat diet-induced fat accumulation and induces adiponectin expression in miceBritish Journal of Nutrition, 2008
- Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish womenBritish Journal of Cancer, 2008
- Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancerBreast Cancer Research, 2007
- Dietary Lignan Intake and Postmenopausal Breast Cancer Risk by Estrogen and Progesterone Receptor StatusJNCI Journal of the National Cancer Institute, 2007
- Ki-67 Expression in Benign Breast Ductal Cells Obtained by Random Periareolar Fine Needle AspirationCancer Epidemiology, Biomarkers & Prevention, 2005
- Endogenous sex hormones and subsequent breast cancer in premenopausal womenInternational Journal of Cancer, 2004
- Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined AnnuallyJNCI Journal of the National Cancer Institute, 1989